📊 Income Statement

Revenue by Product

Acute Care
09M18M26M35M44M52M61M70MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
025M50M75M100M125M150M175M200MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
01020304050607080Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative Expenses
06M12M19M25M31M38M44M50MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EBITDA

EBITDA
-60M-51M-42M-34M-25M-16M-8M1M10MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EPS

EPSEPS Diluted
000001111Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue Variation (%)

Revenue Variation
-3-2-0124578Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
075150225300375450525600Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-3-20234689Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
062125188250312375438500Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Price-to-Earning Ratio

P/E Ratio
-202060100140180220260300Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
01M2M4M5M6M8M9M10MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
012346789Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
011M22M34M45M56M68M79M90MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Free Cash Flow

Cash At End Of Period
02M5M8M10M12M15M18M20MQ3 2024Q4 2024Q1 2025Q2 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
04M8M11M15M19M22M26M30MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025
🏦 Balance Sheet
📈 Key Metrics